|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 72.70 USD | +1.69% |
|
+5.06% | -11.21% |
| 08-12 | Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating | MT |
| 08-07 | Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.69% | +5.06% | +26.26% | +16.77% | -11.21% | +26.99% | +321.69% | +203.93% | - | 3.19B | |
| +0.90% | +3.80% | +28.08% | +30.55% | +8.05% | +41.49% | -0.78% | +25.75% | +99.22% | 83.28B | |
| +8.86% | +129.20% | +149.92% | +209.58% | +392.13% | +435.14% | +24.85% | -62.11% | - | 57.94B | |
| -1.69% | +23.30% | +42.70% | +68.70% | -2.52% | -22.30% | -36.29% | -45.02% | +56.27% | 57.77B | |
| -1.46% | +0.19% | +13.05% | +9.61% | -8.50% | -2.06% | +30.50% | +2.31% | - | 51.75B | |
| +1.74% | +4.43% | -8.88% | -8.39% | -7.08% | +12.37% | +169.64% | +123.89% | +203.70% | 49.35B | |
| +1.13% | +3.31% | +9.63% | +11.88% | +23.18% | +55.61% | -17.57% | -36.57% | -31.57% | 32.03B | |
| +0.46% | +6.37% | +10.38% | +31.55% | +29.40% | +50.29% | +97.27% | +70.64% | +55.90% | 25.91B | |
| +1.19% | +9.17% | +11.00% | +26.50% | +34.30% | +2.97% | +230.86% | +63.06% | - | 22.74B | |
| -0.30% | +4.45% | -0.69% | +4.21% | +38.22% | +58.29% | +118.84% | +156.48% | +359.54% | 16.87B | |
| -5.74% | +1.91% | +55.22% | +14.13% | -7.45% | -1.42% | +795.59% | +596.23% | +6,761.86% | 16.08B | |
| -1.74% | +2.05% | -1.40% | +17.91% | +6.55% | +66.06% | +187.58% | +66.22% | - | 15.93B | |
| -1.45% | -0.98% | +14.21% | +23.31% | +12.23% | +13.86% | -26.32% | -11.23% | -32.06% | 12.91B | |
| -0.12% | -2.76% | -13.29% | -11.95% | +13.76% | +75.32% | +173.17% | +863.68% | +2,641.03% | 10.88B | |
| +2.84% | +4.31% | +2.90% | +15.74% | +40.58% | +130.31% | +177.53% | +550.24% | - | 10.26B | |
| +6.79% | +22.79% | +54.54% | +140.37% | +358.98% | +409.23% | +644.33% | +44.88% | - | 9.13B | |
| -0.86% | +0.53% | +1.75% | +4.69% | -7.36% | -20.03% | -25.72% | -53.57% | -49.17% | 6.97B | |
| -1.97% | -1.55% | +8.99% | +11.80% | +15.99% | +29.39% | +271.07% | +265.57% | - | 6.35B | |
| +0.71% | +2.97% | +26.57% | +48.44% | +91.59% | +134.16% | +338.08% | +547.79% | - | 6.17B | |
| -4.79% | -8.74% | +1.09% | +26.49% | +0.53% | -0.18% | +63.71% | -8.07% | - | 6.06B | |
| Average | +0.31% | +10.47% | +21.60% | +34.59% | +51.07% | +74.77% | +176.90% | +168.21% | +1,006.47% | 25.08B | |
| Weighted average by Cap. | +0.97% | +20.29% | +32.50% | +46.57% | +59.72% | +79.91% | +96.71% | +76.07% | +528.03% |
- Stock Market
- Stocks
- TARS Stock
- Sector Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
